News & Announcements

October 2022 | Statement

Ibis responds to FDA’s announcement to postpone advisory committee meeting for over-the-counter birth control pill

We are frustrated and deeply disappointed by the FDA’s delay of the advisory committee meeting to discuss the application to move a progestin-only birth control pill over the counter (OTC). Birth control pills are safe and effective, and over-the-counter availability would expand equitable...

August 2022 | Statement

New partnership will expand access to comprehensive sexuality education resources in Africa

(Johannesburg, South Africa) – Ibis Reproductive Health, South Africa office is excited to announce a partnership with AMAZE.org , a project of Advocates for Youth implemented in collaboration with organizations around the world. AMAZE.org harnesses the power of digital media to provide...

July 2022 | Media

Let’s talk about Misoprostol—the original abortion pill

July 2022 | Statement

New survey reveals difficulties accessing abortion in Indiana, foreshadows worsening harms now that Roe v. Wade is overturned

With Indiana already ranked #2 in United States for number of restrictive abortion laws, researchers say additional barriers could harm Hoosiers even further (Indianapolis, IN) – Following the US Supreme Court’s decision to overturn Roe v. Wade , a new survey shows that one thing...

July 2022 | Statement

Ibis celebrates the first-ever application for an OTC birth control pill in the United States

For nearly two decades, Ibis Reproductive Health has led a coalition-driven effort involving more than 100 reproductive health, rights, and justice organizations, research and advocacy groups, youth activists, health care providers, prominent medical and health professional associations, regulatory...

June 2022 | Statement

Ibis responds to overturn of Roe v. Wade

Cambridge, MA, June 24, 2022 – Today, the US Supreme Court released a final decision on Dobbs v. Jackson Women’s Health Organization . The decision overturns Roe v. Wade , the ruling that established the constitutional right to abortion in 1973. The case was focused on whether...

May 2022 | Statement

Over-the-counter birth control pills are closer than ever this Free the Pill Day

Following last week’s leaked Supreme Court draft opinion rolling back abortion rights, access to the full range of reproductive health care – including abortion and birth control – is crucial. Over-the-counter (OTC) birth control pills provide one way to expand access during this...

March 2022 | Media

Improving Black reproductive health requires a hard look at the impact of racism

March 2022 | Statement

Announcing the launch of Ibis's Africa Region Strategy for 2022-2025

March 24, 2022 – After several years of planning, coordinating, and strategizing, we are thrilled to announce Ibis’s Africa Region Strategy for 2022-2025 —an extension of our global strategic plan for 2018-2023 , which affirms our commitment to advancing sexual and reproductive...

March 2022 | Statement

Ibis responds to the new World Health Organization (WHO) guidelines on abortion care

March 9, 2022 – Today, the World Health Organization (WHO) released new guidelines around abortion care that synthesize recommendations on clinical practice, health service delivery, and legal and policy interventions to support quality abortion care. These guidelines affirm evidence...

December 2021 | Statement

Ibis responds to oral arguments before the US Supreme Court in Dobbs v Jackson

Cambridge, MA, December 1, 2021 – Today, Supreme Court arguments for the Dobbs v Jackson Women's Health case—which will determine whether all pre-viability prohibitions on elective abortions are unconstitutional—are scheduled to take place. This ban, which would prohibit most...

November 2021 | Statement

The Lancet Global Health: New study shows self-managed abortion with medication is safe and no less effective than clinician-managed medication abortion in a clinical setting

SAFE study shows the effectiveness of misoprostol alone regimens for medication abortion are higher than previously reported in clinical trials SAFE Study Highlights: Self-managed abortion (SMA) with medications is very safe and effective: 93.8% of those who used the mifepristone + misoprostol...

News & Announcements

Pages